Friday, June 17, 2011

ANTIDEPRESSANTS #5

The second group of the commonly used antidepressant is Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs).


MOA: SNRIs bind to pre-synaptic nerve endings and prevent the reuptake of both serotonin and norepinephrine, resulting in greater concentrations of both neurotransmitters in the synaptic clefts to increase neuronal activities.

ADR:
  • Nausea & Vomiting
  • Insomnia
  • Dizziness
  • Sedation
  • Constipation
  • Increase in blood pressure (at high doses)
  • Sexual dysfunction
EX:

  • Venlafaxine hydrochloride (Efexor XR*)
  • Duloxetine                            (Symbalta*)
TU:
  • Depression                                                                             (Venlafaxine & Duloxetine)
  • Anxiety                                                                                   (Venlafaxine)
  • Socialized anxiety disorder                                                    (Venlafaxine)
  • Panic disorder                                                                         (Venlafaxine)
  • Diabetic neuropathy                                                               (Duloxetine)
  • Moderate to severe stress urinary incontinence in women (Duloxetine)
SP:
  • Pregnancy & lactation
  • Avoid sudden withdrawal
  • Moderate to severe renal or hepatic impairment
  • History of myocardial infarction
  • Close blood pressure and cholestrol serum monitoring


No comments:

Post a Comment